Traws Pharma stockholders approve warrant-related share issuances from Dec 2024 private placement

Traws Pharma, Inc.

Proposal 1 to issue >19.99% of shares upon Pre-Funded & Series A Warrants passed: 2,369,987 for, 24,205 against.
Proposal 2 to issue shares to insiders upon warrant exercise approved: 2,370,124 for, 24,039 against.
Quorum of 65.6% (2,396,188 shares) present; adjournment proposal not used as both prior proposals passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.